Abstract:Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Vitamin D plays an important role in metabolism, cellular function and reproduction. Vitamin D has also been suggested to have potential protective effects against many cancers including breast cancer; however, the data from the epidemiological studies have been inconclusive. Our previous meta-analysis have found high dietary vitamin D intake significantly decreased breast cancer risk (RR = 0.91, 95% CI = 0.85-0.97) and women with higher circulating 25(OH)D level showed about 45% (95% CI = 0.38-0.80) decrease in breast cancer risk (Breast Cancer Res Treat. 2010;121(2):469-77). In a population-based case control study with 593 cases and 580 controls from Shanghai area, we have found that 80% of the normal women with severe vitamin D deficiency (less than 20ng/mL), 15.2% were of deficiency status (20 to 30ng/mL). Only 4.8% of women had sufficient vitamin D level (> 30ng/mL). However, in the breast cancer patients, nearly 96.1% were of vitamin D severe deficiency, 3.2% were of vitamin D deficiency and only 0.7% had sufficient levels. Based on a logistic regression analysis, compared to those with the lowest quintile of plasma 25(OH)D level, women with higher level had significant lower breast risk (Q2 vs. Q1, OR = 0.45, 95% CI = 0.33-0.63; Q3 vs. Q1, OR = 0.25, 95% CI = 0.17-0.36; Q4 vs.Q1, OR = 0.09, 95% CI = 0.06-0.15) showing a significant dose-effect relationship (p-trend < 0.001) after adjusted for the co-variants. We also found a seasonal distribution of vitamin D. Significantly lower vitamin D levels were found for the cases and controls in spring and summer (p < 0.01). In the controls the mean level of vitamin D was higher in the summer (17.76ng/ml) and autumn (16.25ng/ml), and lower in the spring (15.67ng/ml) and winter (10.75ng/ml). However, in the breast cancer patients, the plasma level of vitamin D was highest in the autumn (14.38ng/ml) and lowest in the spring (10.16ng/ml). These results provide a strong evidence that vitamin D may have a chemo-preventive effect against breast cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 643. doi:1538-7445.AM2012-643

Genetic evidence supporting the causal role of 25-hydroxyvitamin D levels in the prognosis of ER− breast cancer: A Mendelian randomization study

The Impact of Serum 25-Hydroxyvitamin D, Calcium, and Parathyroid Hormone Levels on the Risk of Coronary Artery Disease in Patients with Diabetes: a Mendelian Randomization Study.

A Putative Causality of Vitamin D in Common Diseases: A Mendelian Randomization Study.

Association of Serum 25-Hydroxyvitamin D with the Incidence of 16 Cancers, Cancer Mortality, and All-Cause Mortality among Individuals with Metabolic Syndrome: a Prospective Cohort Study

Genetically Low Vitamin D Levels, Bone Mineral Density, and Bone Metabolism Markers: A Mendelian Randomisation Study

Association of Vitamin D Levels and Risk of Ovarian Cancer: A Mendelian Randomization Study

Higher Blood 25(OH)D Level May Reduce the Breast Cancer Risk: Evidence from a Chinese Population Based Case-Control Study and Meta-Analysis of the Observational Studies

Correlates of 25-Hydroxyvitamin D among Chinese Breast Cancer Patients.

Bidirectional Mendelian randomisation analysis of the relationship between circulating vitamin D concentration and colorectal cancer risk

Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency

Association of 25-Hydroxyvitamin D with Cardiometabolic Risk Factors and Metabolic Syndrome: a Mendelian Randomization Study

Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation

Causality assessment of circulating Vitamin D level on venous thromboembolism: A Mendelian randomization study

Vitamin D Deficiency Increases Breast Cancer Risk: A Population Based Case-Control Study In The Chinese Population

Genome-Wide Association Study of Serum 25-Hydroxyvitamin D in US Women

An Analysis of Environment-, Individual-, and Tumor-Related Factors Impacting Hypovitaminosis D in Patients with Malignant Tumors

Metabolic Signatures of Genetically Elevated Vitamin D among Chinese: Observational and Mendelian Randomization Study

Causal role of blood metabolites in HER-positive and HER-negative breast cancer: a Mendelian randomization (MR) study

Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis

Investigating the genetic causal relationship between breast cancer and endometrial cancer: A two-sample Mendelian randomization study

Vitamin D receptor expression in invasive breast tumors and breast cancer survival